Saltar al contenido
Merck

Saltar a

U7257

Urotensin II human

≥97% (HPLC), synthetic

Iniciar sesión para ver los precios por organización y contrato.

Acerca de este artículo

Fórmula empírica (notación de Hill):
C64H85N13O18S2
Número CAS:
Peso molecular:
1388.57
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Form:
lyophilized powder
Assay:
≥97% (HPLC)
Biological source:
synthetic


biological source

synthetic

Quality Level

assay

≥97% (HPLC)

form

lyophilized powder

technique(s)

calcium flux assay: suitable

UniProt accession no.

storage temp.

−20°C

SMILES string

CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)[C@@H](C)O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc6ccc(O)cc6)C(=O)N1)C(O)=O

InChI

1S/C64H85N13O18S2/c1-33(2)52(64(94)95)75-61(91)48-32-97-96-31-47(73-59(89)46(29-51(82)83)72-62(92)49-17-11-25-77(49)63(93)53(34(3)78)76-54(84)40(66)22-23-50(80)81)60(90)70-43(26-35-12-5-4-6-13-35)56(86)71-45(28-37-30-67-41-15-8-7-14-39(37)41)58(88)68-42(16-9-10-24-65)55(85)69-44(57(87)74-48)27-36-18-20-38(79)21-19-36/h4-8,12-15,18-21,30,33-34,40,42-49,52-53,67,78-79H,9-11,16-17,22-29,31-32,65-66H2,1-3H3,(H,68,88)(H,69,85)(H,70,90)(H,71,86)(H,72,92)(H,73,89)(H,74,87)(H,75,91)(H,76,84)(H,80,81)(H,82,83)(H,94,95)/t34-,40+,42+,43+,44+,45+,46+,47+,48+,49+,52+,53+/m1/s1

InChI key

HFNHAPQMXICKCF-USJMABIRSA-N

Gene Information

human ... UTS2(10911)

Application

Urotensin II human was used in agonist and antagonist preparation for calcium mobilization assay.[1] The product can also be used as a test compound for studying the impact of dihydropyridine calcium antagonist amlodipine in human internal mammary artery and clinical implications.[2]

Biochem/physiol Actions

A neuroendocrine peptide of the CRF family that was originally isolated from fish brain but is also found in mammalian brain and spinal motor neurons. It is a potent vasoconstrictor. It may be a mediator of stress-induced anorexia.
A neuroendocrine peptide of the CRF family; potent vasoconstrictor.
Human urotensin II is a vasoactive neuropeptide that belongs to CRF family and stimulates arterial smooth muscle contraction, actin stress fiber formation and proliferation via small GTPase RhoA and there downstream effector Rho-kinase activation.[3]The product is also a selective and potent vasoconstrictor agent as well as an agonist for the orphan receptor GPR14.[4]

Other Notes

Lyophilized from 0.1% TFA in H2O

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
P0270SRP8001
biological source

synthetic

biological source

bovine heart

biological source

human

technique(s)

calcium flux assay: suitable

technique(s)

calcium flux assay: suitable

technique(s)

calcium flux assay: suitable

assay

≥97% (HPLC)

assay

-

assay

>90% (SDS-PAGE)

form

lyophilized powder

form

lyophilized powder

form

liquid

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

Gene Information

human ... UTS2(10911)

Gene Information

cow ... CALM3(520277)

Gene Information

human ... CALR(811)


Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Xiao-Yan Bai et al.
The Annals of thoracic surgery, 92(2), 610-616 (2011-06-28)
Graft spasm in the internal mammary artery (IMA) may occur after coronary artery bypass grafting (CABG). We investigated the effect of human urotensin II (hU-II), a cyclic peptide hormone present in human blood and tissues, and the effect of vasodilators
V Sauzeau et al.
Circulation research, 88(11), 1102-1104 (2001-06-09)
The aim of this work was to investigate the coupling of human urotensin II (hU-II) to RhoA activation and regulation of RhoA-dependent functions. The use of the Rho-kinase inhibitor Y-27632 and the development of a membrane-permeant RhoA inhibitor (TAT-C3) allowed
Xiao-Yan Bai et al.
The Annals of thoracic surgery, 90(6), 1952-1957 (2010-11-26)
Graft spasm remains challenging in CABG (coronary artery bypass grafting) surgery. We investigated the inhibitory effect of a dihydropyridine calcium antagonist amlodipine on the vasoconstriction mediated by potassium chloride (KCl), human urotensin-II (hU-II), and U46619 in human internal mammary artery



Número de artículo de comercio global

SKUGTIN
U7257-1MG04061826153451
U7257-.5MG04061832678078

Preguntas

Revisiones

Sin puntuación

Filtros activos